Product NDC: | 50111-794 |
Proprietary Name: | Azithromycin |
Non Proprietary Name: | Azithromycin |
Active Ingredient(s): | 100 mg/mL & nbsp; Azithromycin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50111-794 |
Labeler Name: | Pliva Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065265 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070817 |
Package NDC: | 50111-794-78 |
Package Description: | 10 VIAL, SINGLE-USE in 1 PACKAGE (50111-794-78) > 5 mL in 1 VIAL, SINGLE-USE |
NDC Code | 50111-794-78 |
Proprietary Name | Azithromycin |
Package Description | 10 VIAL, SINGLE-USE in 1 PACKAGE (50111-794-78) > 5 mL in 1 VIAL, SINGLE-USE |
Product NDC | 50111-794 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Azithromycin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20070817 |
Marketing Category Name | ANDA |
Labeler Name | Pliva Inc. |
Substance Name | AZITHROMYCIN MONOHYDRATE |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |